IRIS - Res&Arch Institutional Research Information System - Research & Archive

ROSATI, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.087
EU - Europa 3.400
AS - Asia 2.931
SA - Sud America 515
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 11.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.994
SG - Singapore 1.338
IT - Italia 596
IE - Irlanda 532
SE - Svezia 503
BR - Brasile 421
UA - Ucraina 414
CN - Cina 398
HK - Hong Kong 387
RU - Federazione Russa 375
VN - Vietnam 356
DE - Germania 250
FI - Finlandia 195
FR - Francia 163
GB - Regno Unito 120
KR - Corea 101
IN - India 74
TR - Turchia 50
RO - Romania 48
BD - Bangladesh 44
CA - Canada 40
PL - Polonia 40
AR - Argentina 34
MX - Messico 34
BE - Belgio 30
NL - Olanda 29
UZ - Uzbekistan 28
AT - Austria 25
IQ - Iraq 24
PK - Pakistan 23
ZA - Sudafrica 23
JP - Giappone 22
ES - Italia 20
EC - Ecuador 19
MA - Marocco 16
CZ - Repubblica Ceca 15
CH - Svizzera 13
ID - Indonesia 12
VE - Venezuela 12
GR - Grecia 10
LT - Lituania 10
CO - Colombia 8
JM - Giamaica 8
CI - Costa d'Avorio 7
DZ - Algeria 7
EG - Egitto 7
EU - Europa 7
JO - Giordania 7
LB - Libano 7
PH - Filippine 7
SA - Arabia Saudita 7
CL - Cile 6
KE - Kenya 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
PY - Paraguay 6
TN - Tunisia 6
AZ - Azerbaigian 5
ET - Etiopia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
AM - Armenia 2
AO - Angola 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KH - Cambogia 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
HT - Haiti 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MM - Myanmar 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
UG - Uganda 1
VC - Saint Vincent e Grenadine 1
Totale 11.028
Salva come PNG Salva come JPEG
Città #
Singapore 989
Chandler 581
Dublin 531
Hong Kong 386
San Jose 366
San Mateo 341
Ashburn 282
Perugia 232
Dong Ket 175
Boardman 163
Jacksonville 155
Santa Clara 148
Ann Arbor 143
Moscow 119
Medford 107
Princeton 106
Lauterbourg 103
Seoul 101
Munich 94
Beijing 92
Wilmington 82
Altamura 69
Andover 69
Los Angeles 68
Ho Chi Minh City 60
Helsinki 52
Des Moines 51
New York 51
Lawrence 49
The Dalles 46
Turku 44
São Paulo 42
Bucharest 40
Saint Petersburg 40
Piscataway 37
Woodbridge 36
Hanoi 33
Brussels 30
Dallas 28
Warsaw 26
Tokyo 22
Frankfurt am Main 21
Norwalk 21
Houston 20
Council Bluffs 19
Chennai 18
Izmir 18
Brooklyn 15
Dearborn 15
Falls Church 15
Milan 15
Orem 15
Rio de Janeiro 15
Rome 15
Tashkent 15
Amsterdam 14
Foligno 14
Toronto 14
Belo Horizonte 13
London 13
Shanghai 13
Vienna 13
Curitiba 12
Ankara 11
Johannesburg 11
Mexico City 11
San Francisco 11
Atlanta 10
Boston 10
Guangzhou 10
Hefei 10
Stockholm 10
Assisi 9
Baghdad 9
Barnet 9
Falkenstein 9
Mumbai 9
Poplar 9
Porto Alegre 9
Biên Hòa 8
Denver 8
Manchester 8
New Delhi 8
Redwood City 8
San Paolo di Civitate 8
Tavernelle 8
Abidjan 7
Auburn Hills 7
Columbus 7
Da Nang 7
Istanbul 7
Montreal 7
Quito 7
Amman 6
Brno 6
Caracas 6
Guayaquil 6
Haiphong 6
Kingston 6
Nuremberg 6
Totale 6.836
Salva come PNG Salva come JPEG
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 237
Activity inhibition of cytolytic lymphocytes by omeprazole. 188
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 181
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 180
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 176
Local and systemic immune response to inactivated C. albicans in mice 168
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 167
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 160
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 156
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 152
Group B Streptococcus induces apoptosis in macrophages 149
Cytokine response to inactivated Candida albicans in mice 149
Experimental model of type IV Streptococcus agalactiae (Group B streptococcus) infection in mice with development of septic arthritis. 148
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 143
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 141
Cytokine response to group B streptococcus infection in mice 141
Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection 140
Regolazione redox dell'apoptosi di linfociti B umani. 136
Graft engineering for allogeneic haploidentical stem cell transplantation 135
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 135
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 135
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 134
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 132
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 131
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 129
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 126
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 122
Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages 121
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 121
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 120
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 119
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 118
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 118
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 117
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 115
Silica particle size and shape: in vitro effects on extracellular matrix metabolism and viability of human bronchial epithelial cells. 114
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 114
Local and systemic immune response to inactivated Candida Albicans in mice. 113
B-chronic lymphocytic leukemia cells exert in vitro cytotoxicity mediated by tumor necrosis factor alpha. 112
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 112
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 109
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 107
Citochine infiammatorie in risposta alla C. albicans inattivata 106
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 105
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 105
Is thiol supplementation for potentiang antioxidant defenses a harmless strategy? 104
L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale 104
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 103
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 102
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 100
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 100
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 100
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 100
Inibizione della attività NK da parte dell’omeprazolo 99
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 99
Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. 95
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 95
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 95
Group B streptococci persist inside macrophages. 94
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 92
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 92
Macrophage apoptosis induced by Group B Streptococcus 91
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 90
In vivo generation of LAK-like cells by inactivated Candida albicans cells. 89
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 88
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 87
Cytokine response to group B streptococcus infection in mice 87
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 86
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function. 85
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 83
Inhibition activity of human cytolytic lymphocytes in vitro by omeprazole 83
Impairment of brain mitochondrial functions by ß-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine. 83
Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine 81
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. 80
C. albicans cell wall components as inducers of LAK-like cells in mice 79
Artrite cronica sperimentale indotta nel topo mediante infezione sistemica con Streptococco di Gruppo B, Sierotipo IV 77
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 76
Natural mechanism of resistance to Group B Streptococcus (GBS) type Ia infection in mice. 72
Septic arthritis induced in mice by systemic infection with different serotypes of Group B Streptococci (GBS). 72
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 72
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 71
Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans. 71
Pathogenic effects of group B streptococcus on macrophages 71
Una mannoproteina parietale di C. albicans come modulatore in vivo dell'attività delle cellule NK/LAK 71
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 68
Experimental septic arthritis induced by type IV Group B Streptococcus in mice. 68
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 67
NOTCH and Graft-Versus-Host Disease 65
In vivo modulation of lymphokine-activated killer cell activity by cell wall components of candida albicans. 63
Persistent in vivo activation of NK/LAK cells by inactivated C. albicans and its mannoprotein fraction 63
Modulazione in vivo dell’attività NK/LAK mediante una mannoproteina parietale di C. albicans 63
Immunomodulatory activity of C. albicans and its cell wall components on LAK-like cells induction in mice. 62
Omeprazole inhibition of natural killer cytotoxicity 61
Inibizione in vitro dell’attività citotossica dei linfociti citolitici da parte dell’omeprazolo 61
Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation 58
Una mannoproteina di parete di C. albicans come modulatore in vivo dell’attività delle cellule NK/LAK 55
Componenti di parete della C. albicans come induttori di cellule NK e LAK 54
Patogenicità nel topo di diversi ceppi di Streptococcus di Gruppo B Sierotipo IV 52
Produzione in vivo di citochine da parte della C. albicans inattivata ed induzione di cellule NK/LAK 51
Induzione di cellule NK e LAK in vivo: confronto fra la C. albicans ed alcuni "biological response modifiers" 51
Totale 10.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 0 0 0 0 0 0 0 0 0 0 65 207
2021/20221.217 51 287 21 109 49 12 16 293 18 57 125 179
2022/20231.734 117 238 13 181 154 199 13 86 652 0 51 30
2023/2024712 35 79 48 28 4 20 189 23 65 18 87 116
2024/20251.762 45 158 67 96 221 82 77 118 336 84 322 156
2025/20263.647 259 245 219 497 519 369 607 164 388 303 77 0
Totale 11.306